Pherecydes Pharma Announces the Appointment of Thibaut du Fayet as Chief Operating Officer and Member of the Executive Board
Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections
Source: finanznachrichten.de